Genrate a flow chart expaining the complications of diabeties
Generating Image
Here is a flowchart covering the major complications of diabetes. Here's a quick summary of what it shows:
Starting Point: Diabetes Mellitus (Type 1 or Type 2) leads to chronic hyperglycemia, which drives all downstream complications.
Three main branches:
1. Microvascular Complications (small vessel damage)
- Retinopathy - damage to retinal blood vessels, can lead to blindness
- Nephropathy - kidney damage, progressing to chronic kidney disease (CKD) and end-stage renal disease (ESRD)
- Neuropathy - nerve damage, split into:
- Peripheral: foot ulcers, Charcot joint, amputations
- Autonomic: gastroparesis, orthostatic hypotension, sexual dysfunction
2. Macrovascular Complications (large vessel disease)
- Coronary Artery Disease - myocardial infarction (heart attack)
- Cerebrovascular Disease - stroke, TIA
- Peripheral Arterial Disease - limb ischemia, gangrene, amputation
3. Acute Complications
- DKA (Diabetic Ketoacidosis) - primarily Type 1
- HHS (Hyperosmolar Hyperglycemic State) - primarily Type 2
- Hypoglycemia - from insulin or medication overdose
The core principle linking all complications is that tight glycemic control (HbA1c targets) significantly reduces the risk of developing both microvascular and macrovascular damage.
Make a presentation abt diabeties
Asking for Preferences
Reading File
Reading File
Running Command
Writing File
Running Command
Your presentation is ready!
Diabetes Mellitus Clinical Overview
Presentation · PPTX
Here's what's inside the 10-slide deck (clinical level, navy/blue color scheme):
| Slide | Content |
|---|---|
| 1 | Title slide |
| 2 | Definition & Epidemiology (IDF stats, risk factors) |
| 3 | Classification - T1, T2, Gestational, Other |
| 4 | Pathophysiology - autoimmune cascade vs. DeFronzo's Ominous Octet |
| 5 | Diagnosis - ADA/WHO criteria table (FPG, OGTT, HbA1c, random PG) |
| 6 | Clinical Features - 8 symptoms with icons and mechanisms |
| 7 | Complications - Acute (DKA, HHS, hypoglycaemia) + Micro vs. Macrovascular |
| 8 | Management - lifestyle, T1DM insulin regimens, T2DM drug hierarchy (SGLT2i, GLP-1 RA) |
| 9 | Monitoring & Targets - HbA1c, BP, lipids, renal, eye, foot |
| 10 | Key Takeaways with references (ADA 2024, DCCT/UKPDS) |
This is a shared conversation. Sign in to Orris to start your own chat.